Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09MKL
|
|||
| Former ID |
DNCL003793
|
|||
| Drug Name |
TD-1607
|
|||
| Indication | Gram-positive bacterial infection [ICD-11: 1B74-1G40; ICD-10: A00-B99; ICD-9: 001-139] | Phase 1 | [1] | |
| Company |
Theravance
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01949103) TD-1607 MAD Study in Healthy Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.